GNRH ANTAGONIST PROTOCOL VERSUS GNRH AGONIST LONG PROTOCOL: A RETROSPECTIVE COHORT STUDY ON CLINICAL OUTCOMES AND MATERNAL-NEONATAL SAFETY

GnRH Antagonist Protocol Versus GnRH Agonist Long Protocol: A Retrospective Cohort Study on Clinical Outcomes and Maternal-Neonatal Safety

ObjectiveTo evaluate the clinical outcomes and maternal-neonatal safety of gonadotropin releasing hormone antagonist (GnRH-ant) and gonadotropin releasing hormone agonist (GnRH-a) protocols.MethodsA total OUTERWEARVESTS of 2505 women undergoing their first in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) were retrospectively ana

read more

Expanding the National Drug Abuse Treatment Clinical Trials Network to address the management of substance use disorders in general medical settings

Betty Tai, Steven Sparenborg, Udi E Ghitza, David Liu Center for the Clinical Trials Network, National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland, USA Abstract: The Patient Protection and Affordable Care Act (2010) and the Mental Health Parity and Addiction Equity Act (2008) expand substance use disorder (SUD) care s

read more


PROSPECTS FOR THE DEVELOPMENT OF PUBLIC POLICY IN THE FIGHT AGAINST DRUG TRAFFICKING, THE DIRECTIONS FOR ITS IMPROVEMENT

The article tells about the current state of the General drug situation in the Russian Federation.Illicit traffic in narcotic drugs and psychotropic substances in the realities of the Russian state in recent years has increased significantly, providing a very negative and, in some cases, and "fatal" impact on society as a whole and its individual c

read more